Details of the Drug Combinations

General Information of This Drug (ID: DMJBXO3)

Drug Name

VX-661 DMJBXO3

Indication

Disease Entry	ICD 11	Status	REF
Cystic fibrosis	CA25	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
VX-661 + Ivacaftor	DCSJERV	Ivacaftor	Cystic Fibrosis	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02953314) A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of VX-661/Ivacaftor in Pediatric Subjects With Cystic Fibrosis (CF)